Chief Executive Officer
Mike Coyne is the President and CEO of Lux Research. Mike has spent the majority of his career building technology-enabled information companies in multiple industries.
Prior to joining Lux Research, Mike was CEO of Quantia, Inc., a leading provider of physician engagement solutions for pharma and health systems, which was acquired by Merck’s Aptus Health division. Prior to Quantia, Mike was CEO of the data analytics business Verisk Health, where he spent 11 years. He was one of the primary architects of their growth and acquisition strategy, leading the company from niche player to multi-product market leader. Earlier in his career, Mike worked in corporate development at Verisk Analytics and as a practicing attorney in New York City.
Mike holds an MBA from Fordham University, a JD from St. John's University, and a BA from the College of the Holy Cross.